Laurent Pharmaceuticals joined battle against COVID-19
On Apr. 9, 2020, Laurent Pharmaceuticals announced that a spin off from McGill University planned to test its…
Chugai started phase III clinical trial of Actemra for COVID-19 pneumonia in Japan
On Apr. 8, 2020, Chugai Pharma announced that it is working to start a phase III clinical trial…
Mateon expanded its COVID-19 therapeutic program to include Artemisinin
On Apr. 8, 2020, Mateon Therapeutics announced that its COVID-19 directed antiviral screening program discovered that Artemisinin is…
Texas A&M Researchers designed 3D-printed diffuser to treat COVID-19 patients
On Apr. 8, 2020, a team of Texas A&M University researchers led by Michael R. Moreno, in collaboration…
Biotechnology | COVID-19 | FDA | Therapeutics
Karyopharm to evaluate low dose Selinexor as potential treatment for hospitalized patients with COVID-19
On Apr. 7, 2020, Karyopharm Therapeutics announced plans to initiate a global randomized clinical trial for low dose…
COVID-19 | FDA | Therapeutics
Cumberland Pharma expanded availability of Vaprisol to treat Hyponatremia for critical care COVID-19 patients
On Apr. 7, 2020, Cumberland Pharma announced an initiative to increase availability of Vaprisol (conivaptan hydrochloride) injection for…
FDA approved Emory University human clinical trials for Emory COVID-19 antiviral
On Apr. 7, 2020, the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug application by…
Seattle area philanthropists responded to COVID-19 care and research needs
On Apr. 7, 2020, the University of Washington Medicine (UW) announced that more than $20 million has been…
RedHill Biopharma announced approval of Compassionate Use of Opaganib for COVID-19 in Italy
On Apr. 6, 2020, RedHill Biopharma announced it has received authorization from the Italian National Institute for Infectious…
COVID-19 | FDA | Therapeutics
FDA cleared Mesoblast IND for remestemcel use in COVID-19 ARDS patients
On Apr. 6, 2020, Mesoblast announced it had received clearance from the U.S. Food and Drug Administration (FDA)…
Mateon achieved milestone in development of OT-101, a phase 3 clinical drug candidate, against COVID-19
On Apr. 6, 2020, Mateon Therapeutics announced an update on its rapid antiviral response program targeting coronaviruses, initially…
AIM ImmunoTech announced NCI award of $14.54 million to study Ampligen as part of five Roswell Park-led chemokine modulation clinical trials in melanoma, colorectal and ovarian cancers
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
New antiviral drug from Emory University heading into clinical trials for COVID-19 treatment
On Apr. 6, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced its participation in a clinical trial…
Rice University established COVID-19 research fund
On Apr. 6, 2020, Rice University announced it had established a research accelerator fund to support projects –…
Alzheimer’s trial screening data links high amyloid levels with early stage disease
On Apr. 6, 2020, the first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) study…
Redhill Biopharma announced first Covid-19 patient treated with Opaganib in Israel under Compassionate Use
On Apr. 6, 2020, RedHill Biopharma announced the first patient with confirmed coronavirus (COVID-19) diagnosis had been dosed…
New IHME COVID-19 forecasts find lower hospital bed need, epidemics starting to peak confirms social distancing works
On Apr. 5, 2020, updated COVID-19 estimates from the Institute for Health Metrics and Evaluation (IHME) found that…
Minneapolis Heart Institute Foundation engaged in COVID-19 STEMI research study
On Apr. 6, 2020, the Minneapolis Heart Institute Foundation (MHIF) announced it was serving as the international coordinating…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Non-Profit Research | Therapeutics
Mesa Biotech to develop molecular point-of-care diagnostic test for novel Coronavirus (COVID-19)
On Apr. 4, 2020, Mesa Biotech announced the addition of the novel coronavirus (SARS-CoV-2) to its active influenza…
Mayo Clinic named national site for Convalescent Plasma Expanded Access Program
On Apr. 3, 2020, the FDA announced that the Mayo Clinic Mayo Clinic will be the lead institution…
OHSU launched in-house COVID-19 testing lab
On Apr. 3, 2020, Oregon Health & Science University (OHSU) announced that it had established an in-house COVID-19…
Mary and Ryan Finley donated $3 million to Legacy Health, OHSU to combat COVID-19
On Apr. 3, 2020, Oregon Health & Science University (OHSU) announced that Mary and Ryan Finley, moved by…
Penn Medicine launched trial to evaluate hydroxychloroquine to treat, prevent COVID-19
On Apr. 3, 2020, a trial led by the Perelman School of Medicine at the University of Pennsylvania…
Vir and Alnylam expand collaboration to advance investigational RNAi therapeutics targeting host factors of COVID-19
On Apr. 2, 2020, Vir Biotech and Alnylam Pharma announced an expansion to their broad multi-target existing collaboration…
Cerus announced inclusion of pathogen reduction technology in ISBT recommendations for preparation of COVID-19 convalescent plasma
On Apr. 2, 2020, Cerus announced that the International Society of Blood Transfusion (ISBT) Working Party on Global…
Biotechnology | COVID-19 | FDA | Therapeutics
Incyte initiated phase 3 clinical trial of Ruxolitinib (Jakafi) as treatment for patients with COVID-19 cytokine storm
On Apr. 2, 2020, Incyte announced it was working with the U.S. Food and Drug Administration (FDA) to…
Emergent BioSolutions partnered with U.S. Government to expedite development of plasma-derived therapy for COVID-19
On Apr. 2, 2020, Emergent BioSolutions announced it had entered into a formal partnership with the U.S. government…
COVID-19 | Therapeutics | WHO
CHF Solutions doubled production staff of Aquadex SmartFlow consoles due to hospital demand
On Apr. 2, 2020, CHF Solutions announced it has doubled the production staff that builds its next generation…
Fred Hutch team launched hunt for coronavirus antibodies
On Apr. 2, 2020, a team of scientists at Fred Hutchinson Cancer Research Center in Seattle began searching…
Biotechnology | Diagnostics | Disease | Genomics | Neurology | NIH | Therapeutics
Single mutation leads to big effects in autism-related gene
On Apr. 2, 2020, a study in Neuron offers clues to why autism spectrum disorder (ASD) is more…